Citigroup’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Sell
30,573
-9,084
-23% -$815K ﹤0.01% 2494
2025
Q4
$3.46M Sell
39,657
-40,017
-50% -$3.04M ﹤0.01% 2280
2025
Q3
$4.56M Buy
79,674
+9,239
+13% +$532K ﹤0.01% 2032
2025
Q2
$4.16M Buy
70,435
+9,933
+16% +$642K ﹤0.01% 2035
2025
Q1
$4.43M Buy
60,502
+5,670
+10% +$469K ﹤0.01% 2012
2024
Q4
$4.54M Buy
54,832
+6,668
+14% +$526K ﹤0.01% 2067
2024
Q3
$3.45M Buy
48,164
+8,222
+21% +$580K ﹤0.01% 2171
2024
Q2
$2.74M Sell
39,942
-377
-0.9% -$22.5K ﹤0.01% 2085
2024
Q1
$2.16M Buy
40,319
+9,950
+33% +$535K ﹤0.01% 2375
2023
Q4
$1.62M Sell
30,369
-620
-2% -$30.2K ﹤0.01% 2423
2023
Q3
$1.54M Sell
30,989
-7,165
-19% -$401K ﹤0.01% 2182
2023
Q2
$2.27M Buy
38,154
+13,728
+56% +$782K ﹤0.01% 2083
2023
Q1
$1.38M Buy
24,426
+5,004
+26% +$321K ﹤0.01% 2301
2022
Q4
$1.44M Sell
19,422
-21,583
-53% -$1.47M ﹤0.01% 2291
2022
Q3
$2.44M Buy
41,005
+25,532
+165% +$1.54M ﹤0.01% 2006
2022
Q2
$869K Sell
15,473
-8,613
-36% -$566K ﹤0.01% 2777
2022
Q1
$1.78M Sell
24,086
-5,238
-18% -$364K ﹤0.01% 2466
2021
Q4
$2.12M Buy
29,324
+1,402
+5% +$102K ﹤0.01% 2580
2021
Q3
$2.14M Sell
27,922
-4,823
-15% -$387K ﹤0.01% 2493
2021
Q2
$2.54M Sell
32,745
-90,725
-73% -$6.45M ﹤0.01% 2477
2021
Q1
$7.61M Buy
123,470
+101,485
+462% +$6.43M 0.01% 1528
2020
Q4
$1.43M Buy
21,985
+8,406
+62% +$483K ﹤0.01% 3186
2020
Q3
$672K Sell
13,579
-10,636
-44% -$549K ﹤0.01% 3598
2020
Q2
$1.16M Sell
24,215
-4,814
-17% -$232K ﹤0.01% 3404
2020
Q1
$1.24M Buy
29,029
+5,474
+23% +$270K ﹤0.01% 2946
2019
Q4
$1.39M Buy
23,555
+1,093
+5% +$59.3K ﹤0.01% 3392
2019
Q3
$1.15M Buy
22,462
+2,165
+11% +$103K ﹤0.01% 3489
2019
Q2
$859K Buy
20,297
+3,047
+18% +$132K ﹤0.01% 3818
2019
Q1
$852K Sell
17,250
-54
-0.3% -$2.44K ﹤0.01% 3575
2018
Q4
$750K Buy
17,304
+3,336
+24% +$166K ﹤0.01% 3688
2018
Q3
$793K Buy
13,968
+5,725
+69% +$301K ﹤0.01% 3758
2018
Q2
$416K Buy
8,243
+676
+9% +$35.3K ﹤0.01% 4307
2018
Q1
$377K Sell
7,567
-1,934
-20% -$90.9K ﹤0.01% 4280
2017
Q4
$390K Sell
9,501
-2,892
-23% -$101K ﹤0.01% 4361
2017
Q3
$369K Buy
12,393
+6,443
+108% +$197K ﹤0.01% 4404
2017
Q2
$197K Buy
5,950
+161
+3% +$5.06K ﹤0.01% 4799
2017
Q1
$171K Sell
5,789
-7,386
-56% -$202K ﹤0.01% 4785
2016
Q4
$326K Buy
13,175
+9,467
+255% +$215K ﹤0.01% 4824
2016
Q3
$84K Sell
3,708
-427
-10% -$10K ﹤0.01% 5318
2016
Q2
$98K Sell
4,135
-47,705
-92% -$1.14M ﹤0.01% 5090
2016
Q1
$1.23M Buy
51,840
+27,379
+112% +$669K ﹤0.01% 3087
2015
Q4
$680K Buy
24,461
+20,408
+504% +$512K ﹤0.01% 3541
2015
Q3
$84K Buy
4,053
+53
+1% +$1.34K ﹤0.01% 5085
2015
Q2
$102K Sell
4,000
-5,240
-57% -$133K ﹤0.01% 4973
2015
Q1
$233K Sell
9,240
-9,601
-51% -$234K ﹤0.01% 4397
2014
Q4
$448K Buy
18,841
+15,120
+406% +$335K ﹤0.01% 3981
2014
Q3
$72K Buy
3,721
+2,351
+172% +$48.4K ﹤0.01% 5028
2014
Q2
$32K Sell
1,370
-7,767
-85% -$187K ﹤0.01% 5477
2014
Q1
$243K Sell
9,137
-8,630
-49% -$205K ﹤0.01% 4150
2013
Q4
$358K Buy
17,767
+16,266
+1,084% +$302K ﹤0.01% 4117
2013
Q3
$25K Buy
1,501
+1,370
+1,046% +$23.7K ﹤0.01% 5773
2013
Q2
$2K Buy
+131
New +$2.02K ﹤0.01% 6520

Other funds holding GMED